• Licensed retailers can now order (V)ia Regal, Hill Street’s cannabis-infused pink grape sparkler, through the Ontario Cannabis Store
  • (V)ia Regal Pink Grape Sparkler is the first product launched under the Hill Avenue Cannabis brand
  • It is Canada’s first grape-based cannabis infused beverage, containing 10mg of THC and only 90 calories
  • Hill Street is an award-winning non-alcoholic beverage and cannabis solutions company
  • Hill Street Beverage Company (BEER) is steady, trading at $0.085 per share

Licensed retailers can now order (V)ia Regal, Hill Street’s cannabis-infused pink grape sparkler, through the Ontario Cannabis Store.

(V)ia Regal Pink Grape Sparkler is the first product launched under the Hill Avenue Cannabis brand. It is Canada’s first grape-based cannabis-infused beverage, with a flavour profile unlike any Cannabis infused beverage currently on the shelf. The drink contains 10mg of THC and only 90 calories.

Craig Binkley, interim co-CEO of Hill Street Beverage Company, commented,
“Just like the fine art of winemaking, (V)ia Regal Pink Grape Sparkler underwent a creative development process.”
“The end result delivers tasting notes that build on the rich alcohol-free red wine base and include blackberries, currants, pomegranates, grapefruit, and red wine for a flavour forward, unique beverage experience,” he continued.
(V)ia Regal is an early entrant to the craft beverage shelf at the Ontario Cannabis Store. Hand-crafted with clean, simple ingredients, it is designed to meet the demand for high-quality craft beverages that satisfy a growing number of consumer needs and occasions.
Hill Street is an award-winning non-alcoholic beverage and cannabis solutions company.
Hill Street Beverage Company (BEER) is steady, trading at $0.085 per share as of 11:30 am ET. 
More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.